Alwin R. Tan

Gununa, QLD, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age.

Low-dose-rate brachytherapy and long-term treatment outcomes in patients younger than 60 years of age.

Journal: Journal of contemporary brachytherapy

Published: July 02, 2023

Selective Transcription Factor Blockade Reduces Human Retinal Endothelial Cell Expression of Intercellular Adhesion Molecule-1 and Leukocyte Binding.

Selective Transcription Factor Blockade Reduces Human Retinal Endothelial Cell Expression of Intercellular Adhesion Molecule-1 and Leukocyte Binding.

Journal: International journal of molecular sciences

Published: December 18, 2022

Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience.

Hyaluronic acid rectal spacer in EBRT: Usability, safety and symmetry related to user experience.

Journal: Journal of medical imaging and radiation sciences

Published: May 09, 2022

Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: a multi-institutional analysis of patients' outcomes.

Impact of hydrogel and hyaluronic acid rectal spacer on rectal dosimetry and toxicity in low-dose-rate prostate brachytherapy: a multi-institutional analysis of patients' outcomes.

Journal: Journal of contemporary brachytherapy

Published: April 23, 2021

The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy.

The use of tissue fiducial markers in improving the accuracy of post-prostatectomy radiotherapy.

Journal: Radiation oncology journal

Published: December 19, 2018

Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space.

Improving rectal dosimetry for patients with intermediate and high-risk prostate cancer undergoing combined high-dose-rate brachytherapy and external beam radiotherapy with hydrogel space.

Journal: Journal of contemporary brachytherapy

Published: December 13, 2018

High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.

High dose rate brachytherapy boost for prostate cancer: Biochemical control and the impact of transurethral resection of the prostate and hydrogel spacer insertion on toxicity outcomes.

Journal: Journal of medical imaging and radiation oncology

Published: October 27, 2018

The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial.

The use of hydrogel spacer in men undergoing high-dose prostate cancer radiotherapy: results of a prospective phase 2 clinical trial.

Journal: World journal of urology

Published: April 04, 2018

Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy.

Prospective analysis of hydrogel spacer for patients with prostate cancer undergoing radiotherapy.

Journal: BJU international

Published: March 10, 2018

A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.

A single institution analysis of low-dose-rate brachytherapy: 5-year reported survival and late toxicity outcomes.

Journal: Journal of contemporary brachytherapy

Published: January 14, 2017

Showing 1-10 of 10

Last Updated: 09/26/2026